ABSTRACT
The presence of liver metastases is a very common clinical situation in oncological patients. The liver is the most common site of metastatic disease of epithelial tumours, predominantly from the colon, breast, lung, pancreas, and stomach (1). The true prevalence of metastatic liver disease is unknown, but in an autopsy series, liver metastases were detected in up to 70% of cancer patients (1).
